Progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
RETRACTED ARTICLE:Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
BMC Cancer Open Access 26 November 2018
-
Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
Scientific Reports Open Access 22 December 2015
-
(Z)3,4,5,4′-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level
Scientific Reports Open Access 06 November 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rennick, B.R. et al. J. Pharmacol. Exp. Ther. 91, 210– 217 (1947).
Juliano, R.L. & Ling, V. Biochim. Biophys. Acta 455, 152–162 (1976).
Riordan, J.R. & Ling, V. J. Biol. Chem. 254, 12701–12705 (1979).
Debenham, P.G. et al. Mol. Cell Biol. 2, 881–889 (1982).
Riordan, J.R. et al. Nature 316, 817–819 ( 1985).
Chen, C.J. et al. Cell 47, 381–389 ( 1986).
Cole, S.P. et al. Science 258, 1650–1654 ( 1992).
Bellamy, W.T. Ann. Rev. Pharmacol. Toxixol. 36, 161– 183 (1996).
Kolaczkowski, M. et al. Microb. Drug. Resist. 4, 143– 148 (1998).
Braybrooke, J.P. et al. Cancer Chemother. Pharmacol. 46, 27– 34 (2000).
Nakamura, M. et al. Anticancer Res. 20, 1921– 1925 (2000).
Pierre, A. et al. Cancer Chemother. Pharmacol. 42, 454– 460 (1998).
Oshika, Y. et al. Mod. Pathol. 11, 1059–1063 (1998).
Bakos, E. et al. J. Biol. Chem. 273, 32167–32175 (1998).
Weinstein, J.N. et al. Science 275, 343 ( 1998).
Marthinet, E. et al. Gene Ther. 7, 1224–1233 (2000).
Bartsevich, V.V. & Juliano, R.L. Mol. Pharmacol. 58, 1–10 (2000 ).
Tiberghien, F. et al. J. Med. Chem. 43, 2547– 2556 (2000).
Rights and permissions
About this article
Cite this article
Cancer multidrug resistance. Nat Biotechnol 18 (Suppl 10), IT18–IT20 (2000). https://doi.org/10.1038/80051
Issue Date:
DOI: https://doi.org/10.1038/80051
This article is cited by
-
MicroRNA-495: a therapeutic and diagnostic tumor marker
Journal of Molecular Histology (2023)
-
It Is All about Probiotics to Control Cervical Cancer
Probiotics and Antimicrobial Proteins (2023)
-
RETRACTED ARTICLE:Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
BMC Cancer (2018)
-
Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
Scientific Reports (2015)
-
(Z)3,4,5,4′-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level
Scientific Reports (2015)
